Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical Trial
Status:
Withdrawn
Trial end date:
2021-01-30
Target enrollment:
Participant gender:
Summary
This trial will determine the safety and estimate efficacy of targeted corticosteroids in
mechanically ventilated patients with the hyper-inflammatory sub phenotype of ARDS due to
coronavirus disease 2019 (COVID-19) by implementing a Phase 2A clinical trial.